Effect of Supplements with Bifidobacterium longum and Lactobacillus acidophilus on the Intestinal Microbiota during Administration of Clindamycin

References

• Aronsson B, Möllby R, Nord CE. Occurrence of toxin producing Clostridium difficile in antibiotic associated diarrhea in Sweden. Medical Microbiology and Immunology 1981; 170: 27–35
   PubMed Web of Science ®Google Scholar
• Aronsson B, Möllby R, Nord CE. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden 1980–1982. Journal of Infectious Diseases 1985; 151: 476–481
   PubMed Web of Science ®Google Scholar
• Beerens H. An elective and selective isolation medium for Bifidobacterium spp. Letters in Applied Microbiology 1990; 11: 155–157
   Web of Science ®Google Scholar
• Biasco G, Paganelli GM, Brandi G, Brillanti S, Lami F, Callegari C, Gizzi G. Effect of Lactobacillus acidophilus, Bifidobacterium bifidum on rectal cell kinetics and fecal pH. Italian Journal of Gastroenterology 1991; 3: 142
   Google Scholar
• Black F, Einarsson K, Lidbeck A, Orrhage K, Nord CE. Effect of lactic acid producing bacteria on the human intestinal microflora during ampicil-lin treatment. Scandinavian Journal of Infectious Diseases 1991; 23: 247–254
   PubMed Web of Science ®Google Scholar
• Borthen L, Heimdahl A, Lindqvist L, Nord CE. Determination of volatile fatty acids in saliva and faeces by gas-liquid chromatography: a rapid method for detection of antibiotic-induced changes in the oropharyngeal and gastrointestinal microflora. International Journal of Microbiology 1983; 1: 35–45
   Google Scholar
• Colombel JF, Cortot A, Neut C, Romond C. Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects. Lancet 1987; ii: 43
   Google Scholar
• Erlich M, van Tassel RL, Libby JM, Wilkins TD. Production of Clostridium difficile antitoxin. Infection and Immunity 1980; 28: 1041–1043
   Web of Science ®Google Scholar
• George WL, Rolfe RD, Finegold SM. Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions. Journal of Clinical Microbiology 1982; 15: 1049–1053
   PubMed Web of Science ®Google Scholar
• George WL, Sutter VL, Citron D, Finegold SM. Selective and differential medium for isolation of Clostridium difficile. Journal of Clinical Microbiology 1976; 9: 214–219
   Google Scholar
• Gorbach SL, Chang TW, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987; ii: 1519, (letter)
   Google Scholar
• Goldin BR, Swenson L, Dwyer J, Sexton M, Gorbach SL. Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. Journal of National Cancer Institute 1980; 64: 255–261
   PubMed Web of Science ®Google Scholar
• Golledge CL, McKenzie T, Riley T. Extended spectrum cephalosporins and Clostridium difficile. Journal of Antimicrobial Chemotherapy 1989; 23: 929–931
   PubMed Web of Science ®Google Scholar
• Gotz VP, Romankiewics JA, Moss J, Murray HW. Prophylaxis against ampicillin-induced diarrhoea with a lactobacillus preparation. American Journal of Hospital Pharmacology 1979; 36: 754–757
   PubMedGoogle Scholar
• Hartley MG, Hudson MJ, Swarbrick ET, Hill MJ, Gent AE, Hellicr MD, Grace RH. The rectal mucosa-associated microflora in patients with ulcerative colitis. Journal of Medical Microbiology 1992; 36: 96–103
   PubMed Web of Science ®Google Scholar
• Heimdahl A, Nord CE. Effect of phenoxy-methylpenicillin and clindamycin on the oral, throat and faecal microflora of man. Scandinavian Journal of Infectious Diseases 1979; 11: 233–242
   PubMed Web of Science ®Google Scholar
• Heimdahl A, Nord CE. Colonization of the oropharynx with pathogenic microorganisms: a potential risk factor for infection in compromised patients. Chemoterapia 1985; 4: 186–191
   PubMedGoogle Scholar
• Hotta M, Sato Y, Iwata S, Yamashita N, Sunakawa K, Oikawa T, Tanaka R, Watanabe K, Takayama H, Yaima M, Sekiguchi S, Arai S, Sakurai T, Mutai M. Clinical effects of Bifidobacterium preparations on pediatric intractable diarrhea. Keio Journal of Medicine 1987; 36: 298–314
   Google Scholar
• Hoverstad T, Carlstedt-Duke B, Lingaas E, Midtvedt T, Norin E, Saxerholt H, Steinbakk M. Influence of ampicillin, clindamycin, and metroni-dazole on faecal excretion of short-chain fatty acids in healthy subjects. Scandinavian Journal of Gastroenterology 1986; 21: 621–626
   PubMed Web of Science ®Google Scholar
• Kotz C, Peterson L, Moody J, Savaiano D, Levitt M. Effect of yoghurt on clindamycin-induced Clostridium difficile colitis in hamsters. Digestive Diseases and Sciences 1992; 37: 129–132
   PubMed Web of Science ®Google Scholar
• Lidbeck A, Edlund C, Gustafsson J-Å, Kager L, Nord CE. Impact of Lactobacillus acidophilus on the normal intestinal microflora after administration of two antimicrobial agents. Infection 1988; 16: 329–336
   PubMed Web of Science ®Google Scholar
• Lidbeck A, Gustafsson J-Å, Nord CE. Impact of Lactobacillus acidophilus supplements on the human oropharyngeal and intestinal microflora. Scandinavian Journal of Infectious Diseases 1987; 19: 531–537
   PubMed Web of Science ®Google Scholar
• Lidbeck A, Nord CE. Lactobacilli in relation to human ecology and antimicrobial therapy. International Journal of Tissue Reactions 1991; 13: 115–122
   Google Scholar
• Marsh WW, Hentges DJ, Chavarria JF, Thal WR, Adams MK, Achi R, Mata L. Influence of orally administered antibiotics on faecal pH and volatile fatty acid concentrations of infants and young children. Microbial Ecology in Health and Diseased 1990; 3: 7–13
   Google Scholar
• Marteau P, Pochart P, Flourié B, Pellier P, Santos L, Desjeux J-F, Rambaud J-C. Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans. American Journal of Clinical Nutrition 1990; 52: 685–688
   PubMed Web of Science ®Google Scholar
• Nord CE, Edlund C. Ecological effects of antimicrobial agents on the human intestinal microflora. Microbial Ecology in Health and Disease 1991; 4: 193–207
   Google Scholar
• Nord CE, Heimdahl A, Kager L. Antimicrobial induced alterations of the human oropharyngeal and intestinal microflora. Scandinavian Journal of Infectious Diseases Supplement 1986; 49: 64–72
   PubMedGoogle Scholar
• Nord CE, Heimdahl A, Kager L, Malmborg AS. The impact of different antimicrobial agents on the normal gastrointestinal microflora of humans. Reviews of Infectious Diseases 1984; 6: 270–275
   PubMedGoogle Scholar
• Orrhage K, Lidbeck A, Nord CE. Effect of Bifidobacterium longum supplements on the human faecal microflora. Microbial Ecology in Health and Disease 1991; 4: 265–270
   Google Scholar
• Peltonen R, Eerola E. Direct automatic bacterial analysis of rat stool samples; the effects of diet and medical treatment studied by computerised gas-liquid chromatography of bacterial fatty acids. Microbial Ecology in Health and Disease 1992; 5: 93–103
   Google Scholar
• Rolfe R. ole of volatile fatty acids in colonization resistance to Clostridium difficile. Infection and Immunity 1984; 45: 185–191
   PubMed Web of Science ®Google Scholar
• Rolfe R, Hclebian S., Finegold S. Bacterial interference between Clostridium difficile and normal fecal flora. Journal of Infectious Diseases 1981; 143: 470–475
   PubMed Web of Science ®Google Scholar
• Teraguchi S, Uehara M, Ogasa K, Mitsuoka T. Enumeration of bifidobacteria in dairy products. Japanese Journal of Bacteriology 1978; 33: 753–761, (Cited in Dairy Science Abstracts (1980) 42, 253–254.)
   PubMedGoogle Scholar
• Zoppi G, Deganello A, Benoni G, Saccomani F. Oral bacleriotherapy in clinical practice. European Journal of Pediatrics 1982; 139: 18–21
   PubMed Web of Science ®Google Scholar